Ueda, Tomoya
Ishihara, Ryu
Yoshii, Shunsuke
Li, James Weiquan
Asada, Yuya
Kitagawa, Daiki
Kizawa, Atsuko
Ninomiya, Takehiro
Okubo, Yuki
Kawakami, Yushi
Tani, Yasuhiro
Shichijo, Satoki
Kanesaka, Takashi
Yamamoto, Sachiko
Takeuchi, Yoji
Higashino, Koji
Uedo, Noriya
Michida, Tomoki
Article History
Received: 21 June 2023
Accepted: 3 November 2023
First Online: 12 December 2023
Declarations
:
: This study was approved by the Institutional Review Board of the Osaka International Cancer Institute and performed in accordance with the 2013 revision of the Declaration of Helsinki.
: We used the opt-out method to obtain informed consent for this study.
: Ryu Ishihara has received honoraria from Olympus, FUJIFILM medical, Daiichi-Sankyo, Miyarisan Pharmaceutical, AI Medical Service, Astra Zeneca, MSD, and Ono Pharmaceutical. James Weiquan Li has received honoraria from Boston Scientific and FUJIFILM medical. Satoki Shichijo has received honoraria from Olympus, EA Pharma, AstraZeneca, AI Medical Service, and Janssen Pharmaceutical. Takashi Kanesaka has received honoraria from Olympus, AstraZeneca, and AI Medical Service. Yoji Takeuchi has received honoraria from Olympus, Boston Scientific, Takeda Pharmaceutical Company, EA Pharma, Zeria Pharmaceutical, and Viatris. Noriya Uedo has received honoraria from Olympus, FUJIFILM medical, Boston Scientific, Daiichi-Sankyo, Takeda Pharmaceutical, EA Pharma, Otsuka Pharmaceutical, AstraZeneca, Miyarisan Pharmaceutical, and AI Medical Service. Tomoya Ueda, Shunsuke Yoshii, Yuya Asada, Daiki Kitagawa, Atsuko Kizawa, Takehiro Ninomiya, Yuki Okubo, Yushi Kawakami, Yasuhiro Tani, Sachiko Yamamoto, Koji Higashino, and Tomoki Michida declare that they have no conflict of interest.